Want to see KEQU full AI Analyst Report?
KEQU Stock Chart & Stats
$36.01
-$0.39(-1.08%)
At close: 4:00 PM EDT
$36.01
-$0.39(-1.08%)
Day’s Range― - ―
52-Week Range$33.27 - $58.95
Previous Close$35.62
Volume2.25K
Average Volume (3M)8.77K
Market Cap
$108.06M
Enterprise Value$158.14
Total Cash (Recent Filing)$11.62M
Total Debt (Recent Filing)$30.18M
Price to Earnings (P/E)11.3
Beta0.89
Next Earnings
Sep 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.35
Shares Outstanding2,868,511
10 Day Avg. Volume10,539
30 Day Avg. Volume8,774
Financial Highlights & Ratios
PEG Ratio-0.71
Price to Book (P/B)1.42
Price to Sales (P/S)0.38
P/FCF Ratio7.21
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Margin ExpansionThe sustained gross-margin improvement indicates better pricing, product mix, and execution. If maintained, the stronger margin structure can support profitability and improve the economics of future laboratory projects.
Scaled Growth PlatformMulti-year revenue and EBITDA expansion demonstrates meaningful operating scale and stronger earnings capacity. This creates a larger platform for leveraging manufacturing, distribution, and integrated laboratory-solution capabilities.
Integrated Global OfferingCombining products, installation capabilities, international operations, and the Lab Products Group can strengthen competitive positioning in complex lab fit-outs. A broader integrated offering may improve win rates and support higher-margin opportunities.
Bears Say
Weak Cash ConversionThe disconnect between positive earnings and no recent cash generation reduces confidence in earnings quality. Persistent or recurring weak conversion could constrain reinvestment, debt reduction, and the company’s ability to absorb project volatility.
Higher LeverageHigher leverage reduces financial flexibility if laboratory construction demand weakens or cash conversion remains poor. Debt commitments can limit investment capacity and increase the consequences of execution or project-timing setbacks.
Uneven Revenue TrendThe inconsistent revenue trajectory highlights exposure to construction cycles, project awards, and customer capital spending. Recent net-margin compression suggests that improved gross margins have not fully insulated earnings from softer demand or cost pressure.
Kewaunee Scientific News
KEQU FAQ
What was Kewaunee Scientific Corp.’s price range in the past 12 months?
Kewaunee Scientific Corp. lowest stock price was $33.27 and its highest was $58.95 in the past 12 months.
What is Kewaunee Scientific Corp.’s market cap?
Kewaunee Scientific Corp.’s market cap is $108.06M.
When is Kewaunee Scientific Corp.’s upcoming earnings report date?
Kewaunee Scientific Corp.’s upcoming earnings report date is Sep 09, 2026 which is in 13 days.
How were Kewaunee Scientific Corp.’s earnings last quarter?
Kewaunee Scientific Corp. released its earnings results on Jun 23, 2026. The company reported $1.131 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Kewaunee Scientific Corp. overvalued?
According to Wall Street analysts Kewaunee Scientific Corp.’s price is currently Overvalued.
Does Kewaunee Scientific Corp. pay dividends?
Kewaunee Scientific Corp. pays a Quarterly dividend of $0.19 which represents an annual dividend yield of N/A. See more information on Kewaunee Scientific Corp. dividends here
What is Kewaunee Scientific Corp.’s EPS estimate?
Kewaunee Scientific Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kewaunee Scientific Corp. have?
Kewaunee Scientific Corp. has 2,868,511 shares outstanding.
What happened to Kewaunee Scientific Corp.’s price movement after its last earnings report?
Kewaunee Scientific Corp. reported an EPS of $1.131 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.623%.
Which hedge fund is a major shareholder of Kewaunee Scientific Corp.?
Currently, no hedge funds are holding shares in KEQU
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kewaunee Scientific Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
KEQU Sentiment 100%
Sector Average 56%
Sector Average 56%
Hedge Fund Trend
Increased
By 1.7K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.05%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-8.40%
Trailing 12-Months
Company Description
Kewaunee Scientific Corp.
Kewaunee Scientific Corporation, established in 1906 and based in Statesville, North Carolina, specializes in providing custom furniture and infrastructure systems for scientific, medical, and technical settings. The company manages its operations through distinct domestic and international divisions. Its extensive product line features diverse furniture options crafted from steel, wood, and laminate, along with specialized equipment like fume hoods, biological safety cabinets, laminar flow systems, and ductless hoods. Kewaunee also offers versatile modular and column systems, mobile workstations, carts, durable epoxy resin worksurfaces, sinks, and various accessories, all supported by comprehensive design assistance. These solutions serve a broad client base: Laboratory products are essential for chemistry, physics, biology, and other general science research conducted in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, governmental, and healthcare industries. Technical products are utilized in facilities manufacturing computers and light electronics, as well as by those requiring furniture for computer and networking setups. Laminate casework applications extend to educational, healthcare, and industrial environments. The corporation primarily distributes its offerings through a network of independent dealers, its own subsidiary companies, and a major national distributor.
Technical Analysis
Ownership Overview
6.47% Insiders
11.22% Mutual Funds
14.72% Other Institutional Investors
59.66% Public Companies and
Individual Investors